Search Tag: Heart Failure Treatment

2024 25 Mar

  Novo Nordisk and Cardior Pharmaceuticals announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved.   Cardior is a leader in the discovery and development of therapies that target RNA as a means to...Read more